Sinocare Past Earnings Performance

Past criteria checks 1/6

Sinocare has been growing earnings at an average annual rate of 8.3%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 21.2% per year. Sinocare's return on equity is 5.3%, and it has net margins of 5.3%.

Key information

8.3%

Earnings growth rate

9.2%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate21.2%
Return on equity5.3%
Net Margin5.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Nov 02
We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

May 02
Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Recent updates

Sinocare Inc.'s (SZSE:300298) P/E Still Appears To Be Reasonable

Dec 02
Sinocare Inc.'s (SZSE:300298) P/E Still Appears To Be Reasonable

Is Sinocare (SZSE:300298) Using Too Much Debt?

Nov 17
Is Sinocare (SZSE:300298) Using Too Much Debt?

We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Nov 02
We Think You Can Look Beyond Sinocare's (SZSE:300298) Lackluster Earnings

Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Oct 23
Estimating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return

Oct 03
Sinocare (SZSE:300298) Is Reinvesting At Lower Rates Of Return

Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Aug 07
Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Jul 19
Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Is Sinocare (SZSE:300298) A Risky Investment?

Jun 07
Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

May 02
Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Apr 22
Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Apr 03
Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Revenue & Expenses Breakdown

How Sinocare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300298 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,2062221,582389
30 Jun 244,1843071,530366
31 Mar 244,1903061,468376
31 Dec 234,0592841,431356
30 Sep 234,1373791,406332
30 Jun 234,1103921,383325
31 Mar 234,2154411,389331
01 Jan 233,9524471,335306
30 Sep 223,4632961,217259
30 Jun 223,0812181,148234
31 Mar 222,478128990192
01 Jan 222,361108971182
30 Sep 212,235134993194
30 Jun 212,174147927193
31 Mar 212,095168858190
31 Dec 202,015187788182
30 Sep 202,049287724187
30 Jun 201,936280695173
31 Mar 201,831265672164
31 Dec 191,778251653161
30 Sep 191,651286613137
30 Jun 191,604272587140
31 Mar 191,607276591134
31 Dec 181,551310588129
30 Sep 181,429286543123
30 Jun 181,301333452131
31 Mar 181,112296392100
01 Jan 181,03325835274
30 Sep 1799420634649
30 Jun 179451563760
31 Mar 178491163610
31 Dec 167961153460
30 Sep 167221383280
30 Jun 166741213270
31 Mar 166981553170
31 Dec 156461443020
30 Sep 156341762660
30 Jun 156111912360
31 Mar 155701992070
31 Dec 145451971950
30 Sep 145061911780
30 Jun 144881761670
31 Mar 144501571600
31 Dec 134491651500

Quality Earnings: 300298 has a large one-off loss of CN¥115.8M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 300298's current net profit margins (5.3%) are lower than last year (9.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300298's earnings have grown by 8.3% per year over the past 5 years.

Accelerating Growth: 300298's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300298 had negative earnings growth (-41.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 300298's Return on Equity (5.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:30
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sinocare Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Yanyin ZhuChina International Capital Corporation Limited